Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence.
He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.
Clinical studies have a way of reaching conclusions that do not reflect individual patient experiences. One such study concludes that...
No one wants their geographic region to be associated with a deadly disease. Unfortunately, this has happened in the past...
We have found that FDA drug warnings can sometimes prevent life-threatening adverse effects, but that unintended consequences are common.
A communication researcher explains how it has gone wrong during the COVID-19 pandemic, and what we can do about it.
During the pandemic, public health officials have seemed to operate on this assumption – that confidence conveys is necessary for...
Many social factors put women at a higher risk of infection during a pandemic, since women usually assume the role...
New models of health try to standardize patient care. In the process, they simplify clinical decision-making. But there is a...
For virtual models of care to become sustainable, they must prioritize the patient experience - not only in the clinical...
The CDC released new guidelines for prescribing opioids, offering solace to many patients. But what is not included in the...
Over the past two decades, researchers have gained a great deal of insight into the risks surrounding concussions – some...
We have seen a rise in high deductible insurance policies, much to the chagrin of patients. Insurers should now acknowledge...
Health equity calls for equal patient outcomes. While laudable, it is not what most consider fair. If health equity means...
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy